Premium
Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage
Author(s) -
NdayaOloo Paul,
Pitisuttithum Punnee,
Tornieporth Nadia G.,
Desgrandchamps Daniel,
Munoz Flor M .,
Kochhar Sonali,
Buttery Jim,
Bauwens Jorgen,
Bonhoeffer Jan
Publication year - 2018
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.1140
Subject(s) - economic shortage , dengue vaccine , immunization , meningococcal vaccine , medicine , pandemic , vaccine safety , malaria , virology , dengue fever , public health , immunology , covid-19 , dengue virus , infectious disease (medical specialty) , antibody , disease , linguistics , philosophy , nursing , pathology , government (linguistics)
Vaccines are increasingly based on new constructs, new technologies, and new compounds. Novel immunization programs are rapidly implemented globally. In this article, we highlight selected hot topics of this highly dynamic and broad field of scientific and public health development. The first section focuses on novel vaccines including malaria, dengue, serogroup B meningococcal, and respiratory syncytial virus vaccines and antibodies. The second section is addressing emerging strategies and programmatic challenges including maternal immunization, integrated mother‐child safety monitoring, and finally coping strategies with vaccine shortages.